Rautenberg Susanne, Keller Marco, Leser Charlotte, Chen Cheng-Chang, Bracher Franz, Grimm Christian
Department of Pharmacy - Center for Drug Research, Ludwig-Maximilians-University, Munich, Germany.
Department of Pharmacology and Toxicology, Medical Faculty, Ludwig-Maximilians-University, Munich, Germany.
Handb Exp Pharmacol. 2023;278:249-276. doi: 10.1007/164_2022_605.
Functional characterization of endolysosomal ion channels is challenging due to their intracellular location. With recent advances in endolysosomal patch clamp technology, it has become possible to directly measure ion channel currents across endolysosomal membranes. Members of the transient receptor potential (TRP) cation channel family, namely the endolysosomal TRPML channels (TRPML1-3), also called mucolipins, as well as the distantly related two-pore channels (TPCs) have recently been characterized in more detail with endolysosomal patch clamp techniques. However, answers to many physiological questions require work in intact cells or animal models. One major obstacle thereby is that the known endogenous ligands of TRPMLs and TPCs are anionic in nature and thus impermeable for cell membranes. Microinjection, on the other hand, is technically demanding. There is also a risk of losing essential co-factors for channel activation or inhibition in isolated preparations. Therefore, lipophilic, membrane-permeable small-molecule activators and inhibitors for TRPMLs and TPCs are urgently needed. Here, we describe and discuss the currently available small-molecule modulators of TRPMLs and TPCs.
由于溶酶体离子通道位于细胞内,对其进行功能表征具有挑战性。随着溶酶体膜片钳技术的最新进展,直接测量跨溶酶体膜的离子通道电流已成为可能。瞬时受体电位(TRP)阳离子通道家族的成员,即溶酶体TRPML通道(TRPML1 - 3),也称为黏脂素,以及远亲双孔通道(TPC),最近通过溶酶体膜片钳技术得到了更详细的表征。然而,许多生理学问题的答案需要在完整细胞或动物模型中开展研究。其中一个主要障碍是,已知的TRPML和TPC的内源性配体本质上是阴离子,因此无法透过细胞膜。另一方面,显微注射技术要求高。在分离的制剂中,还存在失去通道激活或抑制所需的必需辅助因子的风险。因此,迫切需要用于TRPML和TPC的亲脂性、可透过膜的小分子激活剂和抑制剂。在此,我们描述并讨论目前可用的TRPML和TPC的小分子调节剂。